Zacks Investment ResearchMon, 04 May 2026 14:16:16 GMTInternational Markets and NovoCure (NVCR): A Deep Dive for InvestorsNVCR+0.85%
Seeking AlphaFri, 01 May 2026 16:35:10 GMTNovoCure: Pancreatic Launch Looks Promising, But I'm Not A Believer YetNVCR+0.85%
Seeking AlphaThu, 30 Apr 2026 18:41:46 GMTNovoCure Limited (NVCR) Q1 2026 Earnings Call TranscriptNVCR+0.85%
Zacks Investment ResearchThu, 30 Apr 2026 13:35:21 GMTNovoCure (NVCR) Reports Q1 Loss, Beats Revenue EstimatesNVCR+0.85%
BenzingaThu, 26 Mar 2026 15:19:39 GMTNovoCure Tumor Treating Fields Shows Improved Outcomes In Tough Pancreatic CancerNVCR+0.85%
Zacks Investment ResearchMon, 09 Mar 2026 16:56:07 GMTNovocure's Optune Lua Gets Japan Reimbursement for NSCLC TreatmentNVCR+0.85%
Zacks Investment ResearchMon, 02 Mar 2026 15:16:16 GMTNovoCure (NVCR) Reliance on International Sales: What Investors Need to KnowNVCR+0.85%
Zacks Investment ResearchThu, 26 Feb 2026 18:21:34 GMTNovoCure (NVCR) Reports Q4 Loss, Beats Revenue EstimatesNVCR+0.85%
Seeking AlphaThu, 26 Feb 2026 16:17:50 GMTNovoCure Limited (NVCR) Q4 2025 Earnings Call TranscriptNVCR+0.85%
